RHUMBLINE ADVISERS - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 59 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q1 2017$13,000
-35.0%
10,989
+6.5%
0.00%
Q4 2016$20,000
-75.3%
10,323
-55.0%
0.00%
Q3 2016$81,0000.0%22,915
+1.8%
0.00%
Q2 2016$81,000
+58.8%
22,515
+114.2%
0.00%
Q1 2016$51,000
-17.7%
10,5120.0%0.00%
Q4 2015$62,00010,5120.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2016
NameSharesValueWeighting ↓
CARL DOMINO INC 58,435$190,0000.18%
VAN DEN BERG MANAGEMENT I, INC 165,900$584,0000.07%
Granite Investment Partners, LLC 141,206$497,0000.04%
ORACLE INVESTMENT MANAGEMENT INC 50,804$179,0000.03%
JW Asset Management, LLC 8,500$30,0000.02%
Psagot Value Holdings Ltd. 55,362$195,0000.01%
Financial Architects, Inc 5,056$18,0000.01%
B. Riley Wealth Advisors, Inc. 48,226$19,0000.00%
Virtu KCG Holdings LLC 43,205$152,0000.00%
Edge Wealth Management LLC 2,000$7,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders